Literature DB >> 21305587

Pathogenesis of reduced or increased bladder sensation.

Kuniko Tsunoyama1, Ryuji Sakakibara, Chiharu Yamaguchi, Tomoyuki Uchiyama, Tatsuya Yamamoto, Tomonori Yamanishi, Osamu Takahashi, Megumi Sugiyama, Masahiko Kishi, Emina Ogawa.   

Abstract

OBJECTIVE: Pathogenesis of reduced or increased bladder sensation is not well known. Hence, we systematically investigated the frequency of reduced or increased bladder sensation in neurologic/mental diseases.
METHODS: We analyzed 911 patients who were referred from within our hospital. Data registries included a diagnosis, a lower urinary tract symptom questionnaire, a urodynamic study, and neurological examinations. Reduced bladder sensation is defined as bladder volume at the first sensation >300 ml. Increased bladder sensation is defined as bladder volume at the first sensation <100 ml. These patients were stratified into those with and without DO.
RESULTS: Neuropathies are the most common cause of reduced bladder sensation (33.3-43.8% in diabetic neuropathy, etc.). Myelopathies are the second most common cause (17.4-25.0% in multiple sclerosis, etc.). Less common is brain diseases (9.6% in multiple system atrophy, etc.). In contrast, myelopathies are the most common cause of increased bladder sensation without DO (25.0-40.0% in spinal forms of systemic lupus erythematosus, Sjogren's syndrome, etc.). Neuropathies are the second most common (17.3-22.2% in post-pelvic organ surgery, diabetic neuropathy, etc.). Less common is brain/mental diseases (20.0% in psychogenic bladder dysfunction, 8.1% in Parkinson's disease, etc.).
CONCLUSION: The present study revealed that neuropathies are the most common cause of reduced bladder sensation in neurologic/mental diseases. Increased bladder sensation without DO occurs mainly in peripheral and central sensory pathway lesions, as well as in basal ganglia lesions and psychogenic bladder dysfunction. Reduced and increased bladder sensation should be a major treatment target for maximizing patients' quality of life.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21305587     DOI: 10.1002/nau.20953

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  6 in total

1.  Urodynamic Assessment of Neuronal Intranuclear Inclusion Disease.

Authors:  Yosuke Aiba; Ryuji Sakakibara; Fang-Ching Lee; Fuyuki Tateno
Journal:  Eur Neurol       Date:  2020-07-09       Impact factor: 1.710

Review 2.  Urological dysfunction in synucleinopathies: epidemiology, pathophysiology and management.

Authors:  Ryuji Sakakibara; Fuyuki Tateno; Tatsuya Yamamoto; Tomoyuki Uchiyama; Tomonori Yamanishi
Journal:  Clin Auton Res       Date:  2017-11-09       Impact factor: 4.435

3.  Underactive and overactive bladders are related to motor function and quality of life in Parkinson's disease.

Authors:  Zhi Liu; Tomoyuki Uchiyama; Ryuji Sakakibara; Tatsuya Yamamoto
Journal:  Int Urol Nephrol       Date:  2015-03-20       Impact factor: 2.370

4.  Diabetic Peripheral Neuropathy and Urological Complications in Type 1 Diabetes: Findings From the Epidemiology of Diabetes Interventions and Complications Study.

Authors:  Rodica Pop-Busui; Barbara H Braffett; Hunter Wessells; William H Herman; Catherine L Martin; Alan M Jacobson; Aruna V Sarma
Journal:  Diabetes Care       Date:  2022-01-01       Impact factor: 19.112

5.  Differential neurodegenerative phenotypes are associated with heterogeneous voiding dysfunction in a coronavirus-induced model of multiple sclerosis.

Authors:  Sanghee Lee; Balachandar Nedumaran; Joseph Hypolite; Brian Caldwell; Michael C Rudolph; Anna P Malykhina
Journal:  Sci Rep       Date:  2019-07-26       Impact factor: 4.379

Review 6.  Overactive Bladder Symptoms Within Nervous System: A Focus on Etiology.

Authors:  Chuying Qin; Yinhuai Wang; Yunliang Gao
Journal:  Front Physiol       Date:  2021-12-10       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.